👉👉👉Breaking news 🗞️ ➡️ #Momelotinib #JAK #ACVR1 approved in the US as the first and only treatment indicated for myelofibrosis patients with anaemia | ⁦#MPNSM ⁦Ruben A. Mesa, MD⁩ ⁦Aaron Gerds MD, MS⁩ ⁦Nicole Kucine, MD, MS⁩ ⁦Raajit Rampal, M.D.Ph.D.⁩ gsk.com/en-gb/media/pr…

🙌 Busy & wonderful day with our spectacular #Leukemia team on both inpatient wards & clinic together ! Thx 🙏 to my awesome team ! L➡️R Rodney Haltom, PA; Dr @s_arora96 ; Naveen Pemmaraju, MD ; Dr Hannah Goulart ; Nichole Ard MPN Research RN || #MPNSM #BPDCN #leusm #TeamPemm #endcancer

Loved reading this article on the importance of addressing surrogate endpoint validation and disease modification in PV!👏 #mpnsm

👏👏 Ross Firestone Icahn School of Medicine at Mount Sinai 💫

Looking forward to reading this! 👏

Dream team this week on hematology 🩸💉 consults!! Joined by MD Anderson Cancer Center co-fellow Eduardo Edelman Saul, MD, Methodist IM resident Jean Michel Saad, and two incredible Texas A&M School of Engineering Medicine medical students Khue Tran and Divek Toprani 🌟🌟

We are 1 week away from the Heme Reports session blast-phase MPNs! Join our crew along with expert discussants Toyosi Odenike Raajit Rampal, M.D.Ph.D. Alba Meira October 24 6:30pm CT - bit.ly/hemereports_mp… Sanam Loghavi, MD صنم لغوی 🔬🧬 Kamran Mirza MD PhD - کامران مرزا Nitin Jain Naveen Pemmaraju, MD

Excited to share our review of CH and inflammation covering clinical applications, pre-clinical mechanisms, and next steps in the field. Thanks to co-authors at Mount Sinai Hematology/Oncology Fellowship and The Tisch Cancer Institute. Online now Critical Reviews in Oncology Hematology (CROH). sciencedirect.com/science/articl…

Great overview by Naveen Pemmaraju, MD from MD Anderson Cancer Center on New Drugs in #MPN 🏅Novel therapies & combination strategies are being developed. #Cost of therapy should be considered to allow #access for #patients 🙏 #leusm #BPDCN #patientadvocacy

#ASH23|One of the best aspects of ASH ➡️ spending time #mentorship with our superstar brilliant Heme/Onc MD Fellows MD Anderson Cancer Center ! Please make sure to follow Dr Hima Atluri Hima Atluri, MD & Dr Hannah Goulart Hannah Goulart on #medtwitter for the latest in our field!

Thank you Hima Atluri, MD and Naveen Pemmaraju, MD !!!!

Double feature by Hima Atluri, MD looking at total oral therapy in AML with IDH mutations, and looking at the effect of WT1 mutations in a multinstitutional cohort. Outstanding presentation and clinical/genomic flexibility!

Thank you MD Anderson Cancer Center ! Appreciate Icahn School of Medicine at Mount Sinai collaborators Dahniel Sastow 🧠Read here ➡️ sciencedirect.com/science/articl…

We have the best Leukemia team ! Important Special thanks 🙏 to Dr .Hannah Goulart & Dr .Hima Atluri, MD for their hard work, dedication in our clinics and for being awesome 👏 MD Anderson Cancer Center Leukemia Clinic team members with us !!! #endcancer #MPNSM #leusm #BPDCN #RareDisease

What an amazing group of investigators! 🙏🏽🙏🏽MD Education Ryan Fitzpatrick Great meeting !!

🎙️ The Fellows Panel is underway at #HOPLive24! Megan Melody MD, MS Alexandra Rojek Seda Tolu Zaker Schwabkey, MD Hima Atluri, MD Hannah Goulart buff.ly/3xNw3wF

Fantastic unanswered questions in #AML session by Naval Daver, M.D. Sanam Loghavi, MD صنم لغوی 🔬🧬 Rami komrokji Mikkael A. Sekeres MD, MS Great discussion focused on importance and optimal sequencing of therapies for patients w AML - particularly those with targetable mutations! #HOPLive24

👉👉👉Shout out to our outstanding MD Anderson Cancer Center hematology/oncology fellow MD’s Dr Hannah Goulart .Hannah Goulart & Dr .Hima Atluri, MD for an amazing job speaking in the Fellows’ Roundtable at #HOPLive24 meeting organized by chadi nabhan MD, MBA, FACP earlier this month! 👏 | #MPNSM #leusm

👉👉👉Delighted to share our brand new review paper 📑 British Journal of Haematology led by Dr Hannah Goulart .Hannah Goulart & Naveen Pemmaraju, MD ➡️ MPN AYA review #MPNSM #AYACSM #endcancer Lucia Masarova, MD Ruben A. Mesa, MD Claire Harrison J.J. Kiladjian British Journal of Haematology | onlinelibrary.wiley.com/doi/10.1111/bj…

📢 Out in Journal of Clinical Oncology Chemo-free tx with #Blina + #ponatinib in Ph+ #ALL safe & effective ⤵️ 👫N=60 newly diagnosed 🔹CMR 83%, NGS negativity 98% ❗Only 2 pts got ASCT 🔸7 relapses (4 in CNS) ▶️ mFU 2 yrs / 3-yr OS 91% / 3-yr EFS 77% #leusm OncoAlert ⤵️ ascopubs.org/doi/abs/10.120…